Bicycle Therapeutics Ownership | Who Owns Bicycle Therapeutics?


OverviewForecastRevenueFinancialsChart

Bicycle Therapeutics Ownership Summary


Bicycle Therapeutics is owned by 60.72% institutional investors, 1.75% insiders, and 37.53% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 15.78% of BCYC shares. T. Rowe Price Health Sciences is the top mutual fund, with 1.74% of its assets in Bicycle Therapeutics shares.

BCYC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBicycle Therapeutics60.72%1.75%37.53%
SectorHealthcare Stocks 57.32%9.83%32.85%
IndustryBiotech Stocks 68.45%9.51%22.05%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp10.89M15.78%$152.39M
Point72 asset management4.55M6.60%$63.77M
Fcpm iii services b.v.3.45M5.00%$48.33M
Westfield capital management co lp2.61M3.78%$36.54M
Armistice capital2.20M3.18%$30.74M
Morgan stanley1.23M2.89%$24.93M
Siren1.84M2.67%$25.75M
Price t rowe associates inc /md/1.59M2.30%$22.19M
Deep track capital, lp1.28M1.85%$17.87B
Tybourne capital management (hk)1.27M1.84%$17.77M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fcpm iii services b.v.3.45M8.16%$48.33M
Aquilo capital management221.91K4.68%$3.11M
Tybourne capital management (hk)1.27M4.46%$17.77M
Baker bros. advisors lp10.89M1.63%$152.39M
Siren1.84M1.14%$25.75M
Nan fung group68.94K0.83%$965.20K
Deep track capital, lp1.28M0.67%$17.87B
Parkman healthcare partners352.48K0.66%$4.93M
Highvista strategies124.43K0.65%$1.74M
Palo alto investors lp248.93K0.54%$3.49M

Top Buyers

HolderShares% AssetsChange
Point72 asset management4.55M0.14%3.66M
Siren1.84M1.14%1.84M
Baker bros. advisors lp10.89M1.63%1.49M
Fcpm iii services b.v.3.45M8.16%1.11M
Westfield capital management co lp2.61M0.16%759.39K

Top Sellers

HolderShares% AssetsChange
Paradigm biocapital advisors lp---3.25M
Deep track capital, lp1.28M0.67%-2.27M
Ra capital management1.09M0.20%-1.16M
Polar capital---1.00M
First light asset management---967.01K

New Positions

HolderShares% AssetsChangeValue
Siren1.84M1.14%1.84M$25.75M
Long focus capital management543.09K0.25%543.09K$7.60M
Caption management163.08K0.02%163.08K$2.28M
Entrypoint capital43.87K0.26%43.87K$614.22K
Nelson, van denburg & campbell wealth management group4.04K0.00%4.04K$56.60K

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-4.00
Mather group, llc.-5.00
Northwestern mutual wealth management-5.00
Wells fargo & company/mn-30.00
Gen-wealth partners-39.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202499-10.00%41,889,6823.58%601.77%44-16.98%3612.50%
Sep 30, 20241101.85%40,440,4271.84%581.00%55-9.84%3228.00%
Jun 30, 202410711.46%39,708,44130.36%931.81%6042.86%25-24.24%
Mar 31, 202496-10.28%30,461,275-2.88%711.14%42-25.00%333.13%
Dec 31, 20231072.88%31,365,344-3.19%790.69%56-6.67%3239.13%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
T. Rowe Price Health Sciences1.20M1.74%-113.57K
Harbor Small Cap Growth Instl986.50K1.43%118.00K
Westfield Capital Mgt Co Sm-Cap Gr Eq986.50K1.43%139.03K
BNP Paribas Health Cr Innovtr Cl Cap676.82K0.98%110.53K
Belfius Equities Cure C Cap556.31K0.81%-
Candriam Eqs L Biotech C USD Cap531.53K0.77%-
Candriam Global Equities Oncology492.11K0.71%125.18K
BNP Paribas US Small Cap Classic R477.45K0.69%111.32K
Polar Capital Biotech S Inc297.67K0.43%-592.95K
Principal SmallCap R5294.20K0.43%97.10K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 06, 2025Thompson Travis Alvin CHIEF ACCOUNTING OFFICERSell$40.29K
Jan 03, 2025Thompson Travis Alvin CHIEF ACCOUNTING OFFICERSell$2.35K
Jan 02, 2025Thompson Travis Alvin CHIEF ACCOUNTING OFFICERSell$24.66K
Jan 02, 2025Young Alethia Chief Financial OfficerSell$19.66K
Jan 02, 2025Arroyo Santiago CHIEF DEVELOPMENT OFFICERSell$69.65K

Insider Transactions Trends


DateBuySell
2025 Q1-15
2024 Q41011
2024 Q3-7
2024 Q2-7
2024 Q1-6

BCYC Ownership FAQ


Who Owns Bicycle Therapeutics?

Bicycle Therapeutics shareholders are primarily institutional investors at 60.72%, followed by 1.75% insiders and 37.53% retail investors. The average institutional ownership in Bicycle Therapeutics's industry, Biotech Stocks , is 68.45%, which Bicycle Therapeutics falls below.

Who owns the most shares of Bicycle Therapeutics?

Bicycle Therapeutics’s largest shareholders are Baker bros. advisors lp (10.89M shares, 15.78%), Point72 asset management (4.55M shares, 6.60%), and Fcpm iii services b.v. (3.45M shares, 5.00%). Together, they hold 27.39% of Bicycle Therapeutics’s total shares outstanding.

Does Blackrock own Bicycle Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Bicycle Therapeutics.

Who is Bicycle Therapeutics’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is Bicycle Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.16% of its assets in 3.45M Bicycle Therapeutics shares, valued at 48.33M$.

Who is the top mutual fund holder of Bicycle Therapeutics shares?

T. Rowe Price Health Sciences is the top mutual fund holder of Bicycle Therapeutics shares, with 1.74% of its total shares outstanding invested in 1.2M Bicycle Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools